posted on 2025-03-13, 17:07authored byJun Jiang, Gang Chen, Weiqin Zhang, Si Qin, Man Li, Shiyi Zhong, Ying Yang, Liuxin Yang, Muqing Shao, Kai Wang, Qin Li, Chen Jiang, Jingfang Yang, Fang Wang, Shuang Qiu, Xiang Li
Copper plays crucial roles in fundamental life processes,
including
proliferation, metabolism, and survival. Copper deficiency is associated
with multiple diseases, such as nonalcoholic fatty liver disease (NAFLD)
and Wilson’s disease. Therapeutic programs targeting copper
supply are prospectively employed for disease intervention. Herein,
we developed biofriendly copper ionophores (HQFs) by
constructing pseudonatural flavonols, which possess flavonoid bioactivity
and enhanced copper transport properties. In cell models and mice,
we found that HQF-mediated copper delivery synergistically,
safely, and efficiently intervened in the development of fatty liver.
Mechanistically, NAFLD remission involves fatty acid metabolism, anti-inflammatory
processes, and pentose phosphate pathway (PPP) enhancement. Our work
is the first to propose the utilization of synergistic copper loading
and flavonoid activity for NAFLD intervention, which may inform the
clinical management of liver disease.